ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,460.48
-0.41%
Dow Jones
39,118.86
-0.12%
US Dollar vs MXN
18.3023
0.12%
Brent Oil
85.325
0.25%
Bitcoin
63,334.29
1.06%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
01/07/202400:30GlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’EU:OSEOSE Immunotherapeutics
01/07/202400:30GlobeNewswire Inc.OSE Immunotherapeutics annonce la publication de résultats précliniques d’efficacité de Lusvertikimab dans la Leucémie Aiguë Lymphoblastique dans le journal ‘Blood’ LSE:0RADOse Immunotherapeutics Sa
01/07/202400:30GlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
01/07/202400:30GlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
01/07/202400:30GlobeNewswire Inc.Multitude SE: Repurchase of own shares 28.06.2024TG:FRUMultitude SE
01/07/202400:30GlobeNewswire Inc.Kalmar specifies its outlook for 2024
01/07/202400:30GlobeNewswire Inc.Sampo plc’s share buybacks 28 June 2024
01/07/202400:30GlobeNewswire Inc.Atlas Luxco S.à r.l., a subsidiary of Atlas Investissement S.A.S., announces public offers to purchase all of the outstanding common shares and SDRs of Millicom International Cellular S.A. for USD 24.00 in cash per Common Share and per SDR
01/07/202400:18Business WireBW LPG Limited - Successful Completion of the Redomiciliation to SingaporeNYSE:BWLPBW LPG Limited
01/07/202400:08PR Newswire (Canada)WestJet confirms end to AMFA strike
01/07/202400:07PR Newswire (Canada)KEENON Robotics a fait une présentation intitulée « Where Humans Meet Machines » lors de la Réunion annuelle 2024 des nouveaux champions du Forum économique mondial, à Dalian : Les robots permettent à l'IA d'entrer dans le monde physique
01/07/202400:05Business WireHAYA Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award
01/07/202400:04CointelegraphNFT sales fell 44% as crypto dipped, memecoins steal ‘mind share’ in Q2COIN:PEPEUSDPepe
01/07/202400:03Alliance NewsAlliance NewsTOP NEWS: Japan's manufacturing sector unexpectedly stalls in June
01/07/202400:01Alliance NewsAlliance NewsTOP NEWS: China's manufacturing sector hits highest level since 2021
01/07/202400:01Business WireReCerise Therapeutics Inc. Selected for Government Project by MOTIE
01/07/202400:00Business WireAndreas & Thomas Strüngmann Award Zeichnet Gründer von HAYA Therapeutics als Erste Preisträger aus
01/07/202400:00Business WireAndreas & Thomas Struengmann Award Honors HAYA Therapeutics Co-founders as Inaugural Winners
01/07/202400:00GlobeNewswire Inc.Addex Shareholders Approve All Resolutions at Annual General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
01/07/202400:00GlobeNewswire Inc.Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ®TG:AYJValneva SE
01/07/202400:00GlobeNewswire Inc.Corbion reports the progress of its € 20 million share buyback program 24 June – 28 June 2024EU:CRBNCorbion N.V.
01/07/202400:00Business WireElliptic Labs Signs Expansion Contract with Oppo
01/07/202400:00Business WireCarmila: Potential Stake Increase in Galimmo SCA to 99.9%NASDAQ:CARMCarisma Therapeutics Inc
01/07/202400:00Business WireCarmila : Participation dans Galimmo SCA potentiellement portée à 99,9%NASDAQ:CARMCarisma Therapeutics Inc
01/07/202400:00GlobeNewswire Inc.Valneva reçoit une autorisation de mise sur le marché en Europe pour le premier vaccin au monde contre le chikungunya, IXCHIQ®TG:AYJValneva SE
01/07/202400:00Business WireCTP Leases Over 100,000 sqm of Industrial and Logistics Space Across Hungary to Automotive Industry Logistics Specialist
01/07/202400:00GlobeNewswire Inc.Start of Day Message
01/07/202400:00Business WireDassault Systèmes and Mistral AI Partner to Offer Trusted, AI-Powered Industry-Grade Solutions to Accelerate the Generative EconomyNASDAQ:DSYBig Tree Cloud Holdings Limited
01/07/202400:00PR Newswire (US)Paving the Way for More Inclusive and Equitable Education for the World's Most Marginalised Students
01/07/202400:00PR Newswire (US)Gunvor and Quercus announce landmark solar development partnership in Italy

Su Consulta Reciente

AMEX
SPY
SPDR S&P 500
NYSE
MCD
McDonalds
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
COIN
SOLUSD
Solana
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
NYSE
BAC
Bank of America
AMEX
XLV
Health Care Select Sector
NASDAQ
TSLA
Tesla
NASDAQ
AMZN
Amazon.com
NYSE
VZ
Verizon Communications
NYSE
CVX
Chevron
NYSE
NKE
Nike
FX
USDMXN
US Dollar vs MXN
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados